Health Care Deal News- November 12, 2012


Brought to you by

November 12, 2012 Issue:


  1. Recent Health Care M&A Deals 
  2. Spotlight on: Biotechnology
  3. Spotlight on: Medical Devices
  4. Webcast Calendar


Recent Health Care M&A Deals





Humana, Inc.

Metropolitan Health Networks, Inc.

$850 million





Crosstex International

SPSmedical Supply Corp.

$32.5 million

 Boston Scientific

 Vessix Vascular

 $125 million





 Takeda Pharmaceutical Company Limited

 Envoy Therapeutics

 $140 million including milestones

Immune Pharmaceuticals, Inc.

EpiCept Corporation

$3.2 million


Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 800-248-1668 to learn about our frequency discounts. Go to, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 800-248-1668 to learn about our frequency discounts.


Spotlight on: Biotechnology
The biotech sector didn’t report any major transactions in September either.  The largest deal was the sale of Complete Genomics (NASDAQ: GNOM) to China-based BGI-Shenzhen for approximately $117.6 million, or $3.15 per share.  The price represents an 18% premium to the prior day close.......Read more


AVAILABLE NOW - New Sector M&A Reports!
Our team of experts at The Health Care M&A Information Source has been working around the clock to bring you the inside scoop on the latest in the health care M&A market. Our newest M&A reports are loaded with crucial transaction information, current and historic, to help you make smart investment decisions in these health care sectors: Biotechnology; Home Health and Hospice; Hospital; Managed Care; Medical Device; Not-for-Profit Health Care; and Pharmaceutical.


Spotlight on: Medical Devices

In one of the largest transactions of the month, Medtronic Inc. (NYSE: MDT) has agreed to purchase China Kanghui Holdings (NYSE: KH) for $30.75 per share, representing a 22% premium.  China Kanghui makes orthopedic implants and associated instruments for trauma, spine and joint reconstruction.  Net of KH’s cash, the transaction value comes to $775 million........Read more

Conference Calendar...Click here to see more